To sum up, we identified seven genes (GRIA1, GRIA2, GRIK1, GRIK4, GRM3, GLUL, BCAT1) whose mRNA expression may serve as potential molecular biomarker candidates to distinguish glioblastoma and brain metastases tissue derived from surgical resections. This evidence concerns the gene BCAT1 and glioblastoma.